Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

554
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
554
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

665
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
665
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

250
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
250
Glaucoma: Overview01:25

Glaucoma: Overview

740
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
740

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Non-Infectious Choroiditis Subdivided into Its Diverse Pathophysiological Sub-Groups Is the Best-Known and Most Appropriate Nomenclature to Date for the Reclassification and Diagnosis of Former White Dot Entities.

Diagnostics (Basel, Switzerland)·2026
Same author

Hemolytic Glaucoma Following Intravitreal Aflibercept Injection for Age-Related Macular Degeneration: A Case Report.

The American journal of case reports·2026
Same author

The effect of improving cervical extension function on quality of life in patients with dropped head syndrome.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association·2026
Same author

Clinical performance of the multiplex solid-phase "Direct Strip PCR" for infectious uveitis: a multicenter diagnostic accuracy study.

Japanese journal of ophthalmology·2026
Same author

Tattoo-Associated Sarcoid-like Uveitis: A Multicenter Registry Study.

Biomedicines·2026
Same author

Necrotic-cell-activated macrophages drive an ERK-Bcl-xL survival pathway in osteoclasts and confer bisphosphonate resistance.

Biochemical and biophysical research communications·2026

相关实验视频

Updated: Sep 9, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.5K

早期的前列腺素E治疗改善了视力中心视网膜动脉封闭的结果:一项回顾性研究

Hiroki Sano1, Ryoji Yanai2, Hirotaka Kondo1

  • 1Department of Ophthalmology, Tokushima Red Cross Hospital, Komatsushima, Japan.

Frontiers in ophthalmology
|September 5, 2025
PubMed
概括

在中枢视网膜动脉封闭 (CRAO) 患者中,早期使用前列腺素E1 (PGE1) 显著改善视力. 这表明PGE1是治疗视网膜缺血紧急情况的有希望的疗法.

关键词:
中央视网膜动脉封闭神经保护光学连贯断层扫描质腺素 E1视网膜缺血视觉结果

更多相关视频

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

3.9K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.5K

相关实验视频

Last Updated: Sep 9, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.5K
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

3.9K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.5K

科学领域:

  • 眼科 眼科
  • 血管医学
  • 药理学

背景情况:

  • 中央视网膜动脉封闭 (CRAO) 是一种导致突然视力丧失的危险状况.
  • 目前对CRAO的治疗缺乏确定的疗效.
  • 前列腺素E1 (PGE1) 具有血管扩张和细胞保护性质,表明其潜在的治疗价值.

研究的目的:

  • 评估早期静脉注射Prostaglandin E1 (PGE1) 的疗效,以改善中枢视网膜动脉封闭 (CRAO) 的患者的视觉结果.
  • 用PGE1治疗的CRAO患者的视觉敏度和视网膜结构变化与传统治疗进行比较.

主要方法:

  • 这是一项追溯性研究,比较CRAO患者在症状出现后24小时内静脉注射PGE1,然后再口服.
  • 静脉注射PGE1治疗时间为5天.
  • 视觉敏度和视网膜参数 (最大视网膜厚度,中心视网膜厚度,动脉静脉直径) 被评估并与PGE1和对照组进行比较.

主要成果:

  • 与对照组相比,PGE1组在一个月内显示出明显更好的最佳视力度.
  • 在基线视网膜厚度 (最大视网膜厚度,中央视网膜厚度) 之间没有观察到显著的差异.
  • 在PGE1组的基线最大视网膜厚度与一个月的视觉敏度有负相关性. 视网膜静脉直径在治疗后保持不变.

结论:

  • 在中枢视网膜动脉封闭 (CRAO) 患者中,早期静脉注射前列腺素E1 (PGE1) 似乎可以改善视力恢复.
  • 作为急性视网膜缺血的有效治疗方法,PGE1具有潜力.
  • 需要进一步的研究来证实这些发现,并确定PGE1在CRAO管理中的作用.